日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lead Structure-Based Hybridization Strategy Reveals Major Potency Enhancement of SirReal-Type Sirt2 Inhibitors

基于先导化合物结构的杂交策略揭示了SirReal型Sirt2抑制剂效力的显著提升

Frei, Matthias; Wirawan, Ricky; Wein, Thomas; Bracher, Franz

Lead-Structure-Based Rigidization Approach to Optimize SirReal-Type Sirt2 Inhibitors.

基于先导化合物结构的刚性化方法优化 SirReal 型 Sirt2 抑制剂

Frei Matthias, Wein Thomas, Bracher Franz

Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD(+) co-factor binding.

定制的 SirReal 型抑制剂通过配体稳定和破坏 NAD(+) 辅因子结合来增强 SIRT2 抑制作用

Wirawan Ricky, Frei Matthias, Heider Anna, Papenkordt Niklas, Friedrich Florian, Wein Thomas, Jung Manfred, Groll Michael, Huber Eva M, Bracher Franz

Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches

利用两种不同的浓度-QTc模型方法评估维利西呱的QTc效应

Ruehs, Hauke; Solms, Alexander; Frei, Matthias; Becker, Corina; Trujillo, Maria E; Garmann, Dirk; Meyer, Michaela

Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview

选择性孕激素受体调节剂维拉普利生的临床药代动力学和药效学:全面概述

Schultze-Mosgau, Marcus-Hillert; Ploeger, Bart A; Frei, Matthias; Höchel, Joachim; Rottmann, Antje

Nanostructure of nickel-promoted indium oxide catalysts drives selectivity in CO(2) hydrogenation

镍促进的氧化铟催化剂的纳米结构驱动CO(2)加氢反应的选择性

Frei, Matthias S; Mondelli, Cecilia; García-Muelas, Rodrigo; Morales-Vidal, Jordi; Philipp, Michelle; Safonova, Olga V; López, Núria; Stewart, Joseph A; Ferré, Daniel Curulla; Pérez-Ramírez, Javier

Application of Physiologically-Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin

在莫西沙星儿科研发过程中,应用生理学和群体药代动力学模型进行剂量探索和确认

Willmann, Stefan; Frei, Matthias; Sutter, Gabriele; Coboeken, Katrin; Wendl, Thomas; Eissing, Thomas; Lippert, Jörg; Stass, Heino